Most Recent
Domino's Pizza and Precision Tracking have reached a settlement on the eve of trial in a hard-fought battle by the US pizza giant to invalidate two of the Australian tech startup's patents covering a GPS system that helps customers locate delivery drivers in real-time.
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.
Aurizon has won a request to view documents from Qube Holdings in the ACCC's case alleging it reached an anti-competitive agreement with Pacific National for the sale of its intermodal freight business, as it pushes back against the competition regulator's claim that there were other buyers vying for the business.
An investor suing property investment group Aviation 3030 can't avoid payment of half a million dollars in security for litigation costs because of a parallel enforcement action by the corporate regulator, a judge has ruled.
The Australian Patent Office has thrown out Fisher & Paykel Healthcare's opposition to a patent for a gas supply apparatus used to treat respiratory conditions owned by California-based medical equipment manufacturer, ResMed.
Aussie swimwear company Seafolly Pty Ltd and global logistics company Seko have agreed to settle their dispute over a shipping agreement that went south.
The judge overseeing the competition lawsuit brought by the ACCC over Aurizon's proposed sale of its Queensland intermodal business to Pacific National has denied the regulator's bid for an injunction against Pacific, saying it amounted to micro-managing that could discourage "normal competitive behaviour".
The ACCC has won its request for an injunction blocking rail freight operator Aurizon from shutting its intermodal business down while a competition lawsuit the regulator filed over Aurizon's proposed sale of the business to Pacific National makes its way through the court.
One of Australia's largest debt collectors, ACM Group, harassed and coerced vulnerable customers -- including a stroke victim -- by bombarding them with phone calls and making empty threats of litigation, the Federal Court found Monday.
Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals' patents covering sleep drug Circadin, with a court ruling legal professional privilege was waived in a phone conversation between a DLA Piper lawyer and the company's founder.